Albireo Pharma Inc (ALBO)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Ronald H. Cooper
Employees:
39
10 POST OFFICE SQUARE, SUITE 502 SOUTH, BOSTON, MA 02109
857-415-4774

Albireo Pharma, Inc. is a pharmaceutical company engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions. The company was founded by Jan Mattsson on December 8, 2003 and is headquartered in Boston, MA.

Data derived from most recent annual or quarterly report
Market Cap 562.655 Million Shares Outstanding19.256 Million Avg 30-day Volume 117.004 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 43.41 / 27.23 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from ALBO instead.

View recent insider trading info

Funds Holding ALBO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALBO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

951 total shares from 5 transactions

Exercise Derivative Conversion (M)

12 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HORN PATRICK TAYLOR CHIEF MEDICAL OFFICER

  • Officer
12,355 2021-10-22 4

DUNCAN JASON CHIEF LEGAL OFFICER AND GC

  • Officer
7,355 2021-10-22 6

HARFORD SIMON N.R. CFO AND TREASURER

  • Officer
12,614 2021-10-11 6

STEPHENSON PAMELA CHIEF COMMERCIAL OFFICER

  • Officer
26,063 2021-09-27 5

COOPER RONALD HAROLD WILFRED PRESIDENT AND CEO

  • Officer
  • Director
103,700 2021-09-17 2

JEFFS ROGER

  • Director
8,000 2021-06-24 1

SCOON DAVEY

  • Director
8,000 2021-06-24 1

CHISWELL DAVID

  • Director
8,000 2021-06-24 1

GUTCH MICHAEL

  • Director
8,000 2021-06-24 1

KLIBANSKI ANNE

  • Director
8,000 2021-06-24 1

OKEY STEPHANIE

  • Director
8,000 2021-06-24 1

MATTSSON JAN CHIEF SCIENTIFIC OFFICER

  • Officer
91,318 2021-03-01 3

CARTER MARTHA J. CHIEF REGULATORY OFFICER

  • Officer
5,500 2021-01-21 1

GRAHAM MICHELLE CHIEF HUMAN RESOURCES OFFICER

  • Officer
5,500 2021-01-21 1

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
2,360,139 2020-09-14 0

SONI PARESH CHIEF MEDICAL OFFICER

  • Officer
0 2018-06-08 0

SHEA THOMAS A. CFO AND TREASURER

  • Officer
0 2018-06-08 0

BROWN JULIA R

  • Director
4,500 2018-06-07 0

PHASE4 PARTNERS LTD

PHASE4 VENTURES III GENERAL PARTNER LTD

PHASE4 VENTURES III LP

1,065,447 2018-01-30 0

PHASE4 PARTNERS LTD

PHASE4 VENTURES III GENERAL PARTNER LTD

PHASE4 VENTURES III GP LP

PHASE4 VENTURES III LP

1,065,447 2018-01-30 0

ASTRAZENECA PLC

ASTRAZENECA AB

  • 10% Owner
508,141 2017-12-01 0

ZORN PETER A CHIEF CORP. OFFICER, GC & SEC

  • Officer
0 2017-08-21 0

POLLARD-KNIGHT DENISE

  • Director
  • 10% Owner
0 2017-06-16 0

PRESTON HEATHER

  • Director
0 2017-01-23 0

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • 10% Owner
777,096 2016-11-03 0

MCKINNON ALASTAIR

  • 10% Owner
1,165,447 2016-11-03 0

SERMON CHARLES

  • 10% Owner
1,165,447 2016-11-03 0

LIEBERMAN IRA

  • Director
0 2016-02-24 0

MORRIS ARLENE

  • Director
0 2016-02-24 0

LORBER DANIEL

  • Director
0 2016-02-24 0

GINSBERG BARRY H

  • Director
0 2016-02-24 0

BAVIER PAUL S GENERAL COUNSEL

  • Officer
0 2016-01-21 0

GEMIGNANI GARY G CHIEF FINANCIAL OFFICER

  • Officer
0 2016-01-21 0

DESOUZA ERROL B CEO

  • Officer
  • Director
159,416 2015-09-30 0

KRASNER ALAN SETH CHIEF MEDICAL OFFICER

  • Officer
0 2014-12-19 0

MICHEL GERARD J CFO, VP OF CORP AND DEV/TREAS

  • Officer
43,810 2014-03-12 0

PEREIRA BRIAN JG

  • Director
0 2014-03-04 0

STEINER ERIK VICE-PRESIDENT, OPERATIONS

  • Officer
0 2013-12-23 0

SANDERS CHARLES A

  • Director
0 2012-03-08 0

CASEY DONALD M JR.

  • Director
0 2012-03-08 0

URCIUOLI J ARTHUR

  • Director
1,969 2011-09-30 0

STEINER SOLOMON

  • Director
1,555,026 2011-09-22 0

KROIN DAVID

  • Director
0 2010-03-02 0

WEISMAN SCOTT

  • Director
298,136 2010-03-01 0

KROIN DAVID

GREAT POINT PARTNERS LLC

  • Director
1,009,188 2010-01-13 0

GREAT POINT PARTNERS I LP

  • 10% Owner
1,453,918 2009-08-14 0

ORBIMED ADVISORS LLC

ISALY SAMUEL D

  • Director
1,485,904 2009-06-09 0

WERTHEIMER SAMUEL P

  • Director
1,485,904 2009-06-09 0

POHL RODERIKE VICE PRESIDENT RESEARCH

  • Officer
No longer subject to file 2008-12-13 0

PFUTZNER ANDREAS CHIEF MEDICAL OFFICER IN EUROP

  • Officer
2,000 2008-11-06 0

WARE R TIMMIS CORP. SECY AND GENERAL COUNSEL

  • Officer
118,740 2008-04-17 0

STEINER VENTURES LLC

  • 10% Owner
4,044,266 2008-02-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DUNCAN JASON - Officer CHIEF LEGAL OFFICER AND GC

2021-10-25 18:30:49 -0400 2021-10-25 S 217 $29.21 d 7,355 direct

DUNCAN JASON - Officer CHIEF LEGAL OFFICER AND GC

2021-10-25 18:30:49 -0400 2021-10-22 S 95 $28.85 d 7,572 direct

HORN PATRICK TAYLOR - Officer CHIEF MEDICAL OFFICER

2021-10-25 18:41:50 -0400 2021-10-22 S 95 $28.83 d 12,355 direct

HARFORD SIMON N.R. - Officer CFO AND TREASURER

2021-10-12 16:01:48 -0400 2021-10-11 S 93 $30.23 d 12,614 direct 2.8467 -2.2509 3.4095 3 -2.2509 6

STEPHENSON PAMELA - Officer CHIEF COMMERCIAL OFFICER

2021-09-28 16:32:33 -0400 2021-09-27 S 451 $32.05 d 26,063 direct yes 3.414 -2.8505 3.5134 3 -2.8505 6

COOPER RONALD HAROLD WILFRED - Director - Officer PRESIDENT AND CEO

2021-09-20 16:03:36 -0400 2021-09-17 M 11,973 $19.19 a 68,433 direct 0.5381 -0.2849 3.5771 3 -0.6964 4

COOPER RONALD HAROLD WILFRED - Director - Officer PRESIDENT AND CEO

2021-09-20 16:03:36 -0400 2021-09-17 M 11,973 d 43,027 direct

COOPER RONALD HAROLD WILFRED - Director - Officer PRESIDENT AND CEO

2021-09-20 16:03:36 -0400 2021-09-17 F 7,760 $29.61 d 60,673 direct 0.5381 -0.2849 3.5771 3 -0.6964 4

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ALBIREO PHARMA INC ALBO 2021-10-25 22:15:03 UTC -0.2546 0.3246 150000
ALBIREO PHARMA INC ALBO 2021-10-25 21:45:03 UTC -0.2546 0.3246 150000
ALBIREO PHARMA INC ALBO 2021-10-25 21:15:03 UTC -0.2546 0.3246 150000
ALBIREO PHARMA INC ALBO 2021-10-25 20:45:03 UTC -0.2546 0.3246 150000
ALBIREO PHARMA INC ALBO 2021-10-25 20:15:03 UTC -0.2546 0.3246 150000
ALBIREO PHARMA INC ALBO 2021-10-25 19:45:04 UTC -0.2546 0.3246 150000
ALBIREO PHARMA INC ALBO 2021-10-25 19:15:03 UTC -0.2546 0.3246 150000
ALBIREO PHARMA INC ALBO 2021-10-25 18:45:02 UTC -0.2793 0.3493 150000
ALBIREO PHARMA INC ALBO 2021-10-25 18:15:03 UTC -0.2793 0.3493 150000
ALBIREO PHARMA INC ALBO 2021-10-25 17:45:03 UTC -0.2793 0.3493 150000
ALBIREO PHARMA INC ALBO 2021-10-25 17:15:03 UTC -0.2793 0.3493 150000
ALBIREO PHARMA INC ALBO 2021-10-25 16:45:02 UTC -0.2793 0.3493 150000
ALBIREO PHARMA INC ALBO 2021-10-25 16:15:03 UTC -0.2793 0.3493 150000
ALBIREO PHARMA INC ALBO 2021-10-25 15:45:03 UTC -0.2793 0.3493 150000
ALBIREO PHARMA INC ALBO 2021-10-25 15:15:03 UTC -0.2793 0.3493 150000
ALBIREO PHARMA INC ALBO 2021-10-25 14:45:02 UTC -0.2678 0.3378 150000
ALBIREO PHARMA INC ALBO 2021-10-25 14:15:03 UTC -0.2678 0.3378 150000
ALBIREO PHARMA INC ALBO 2021-10-25 13:45:03 UTC -0.2678 0.3378 150000
ALBIREO PHARMA INC ALBO 2021-10-25 13:15:03 UTC -0.2678 0.3378 150000
ALBIREO PHARMA INC ALBO 2021-10-25 12:45:04 UTC -0.2678 0.3378 150000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments